Clinical Trial Update: Effects of Ramelteon on Driving Ability [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the impact of ramelteon on driving performance in individuals with insomnia. The update reports study findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• ROZEREM (ramelteon)

Snippet

Sponsor: Utrecht Institute for Pharmaceutical Sciences | Conditions: Insomnia | Phase 1 | Status: COMPLETED